Subramanian Loganathan

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer

Hope S. Rugo, Abhijit Barve, Cornelius F. Waller et al. · JAMA · 2016 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

Suresh Kumar, Rosemarie de Souza, Milind Nadkar et al. · Expert Opinion on Biological Therapy · 2021 · 33 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study

Harold E. Lebovitz, Alexander Fleming, Alan D. Cherrington et al. · Expert Opinion on Pharmacotherapy · 2022 · 17 citations

Medicine, Endocrinology, Pharmacotherapy +17

Ultrasound assisted polymerization of N-vinyl imidazole under phase-transfer catalysis condition – A kinetic study

Subramanian Loganathan, Venugopal Rajendran · Ultrasonics Sonochemistry · 2012 · 15 citations

Natural Sciences, Chemical Engineering, Chemistry +14

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer

Hope S. Rugo, Eduardo J. Pennella, Unmesh Gopalakrishnan et al. · Breast Cancer Research and Treatment · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +17